Deciphera Pharmaceuticals Inc (DCPH)
25.48
+0.01
(+0.04%)
USD |
NASDAQ |
May 22, 16:00
25.48
0.00 (0.00%)
After-Hours: 16:27
Deciphera Pharmaceuticals Profit Margin (Quarterly): -100.2% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -100.2% |
| December 31, 2023 | -97.71% |
| September 30, 2023 | -114.5% |
| June 30, 2023 | -126.8% |
| March 31, 2023 | -148.3% |
| December 31, 2022 | -126.4% |
| September 30, 2022 | -119.7% |
| June 30, 2022 | -132.5% |
| March 31, 2022 | -160.5% |
| December 31, 2021 | -365.3% |
| Date | Value |
|---|---|
| September 30, 2021 | -343.8% |
| June 30, 2021 | -298.8% |
| March 31, 2021 | -243.7% |
| December 31, 2020 | -322.0% |
| September 30, 2020 | -412.3% |
| June 30, 2020 | -948.4% |
| March 31, 2020 | -117.4K% |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -85.84% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-117.4K%
Minimum
Mar 2020
-85.84%
Maximum
Jun 2019
-6.75K%
Average
-154.4%
Median
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -100.4% |
| Dynavax Technologies Corp | -17.17% |
| Gilead Sciences Inc | -62.37% |
| Esperion Therapeutics Inc | 44.30% |
| SINTX Technologies Inc | -286.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.29% |
| Return on Assets | -38.85% |
| Return on Invested Capital | -50.29% |
| Gross Profit Margin (Quarterly) | 95.36% |
| Operating Margin (Quarterly) | -108.6% |
| Return on Net Operating Assets | -200.2% |